Navigation Links
Nick Pace Named EVP -- Operations, Compliance, and Regulatory
Date:3/25/2013

RICHMOND, Va., March 25, 2013 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) has named Nicholas J. Pace , former executive vice president with Amerigroup as Executive Vice President of Operations, Compliance and Regulatory at the growing health management and advanced testing company.

"The healthcare and biotechnology industries are well-known for their operational, compliance, and regulatory complexities, and Nick is similarly well-known for his capabilities in helping companies operate effectively and excel within this environment," said Tonya Mallory , CEO, President, and Co-founder of HDL, Inc. "We look forward to having Nick on our growing team of healthcare and business leaders."

Most recently, Pace served as executive vice president, general counsel and secretary of Amerigroup, a multi-state publicly traded managed care organization focused on publicly sponsored health programs. Prior to joining Amerigroup in 2006, Pace served as assistant general counsel of CarMax, Inc., the publicly traded auto retailer based in Goochland County, and earlier in his career practiced corporate law at a firm in Silicon Valley. Prior to practicing law, the cum laude graduate of the University of Richmond T.C. Williams School of Law served as a consultant in Ernst & Young's tax group. Pace also holds a master's degree in business administration from the E. Claiborne Robins School of Business at U of R.

"I sincerely appreciate the opportunity to join such a fast-growing company that is having a remarkably positive impact on health outcomes for thousands of Americans. I look forward to helping the company continue its successful growth and expand its offerings that allow for the delivery of more efficient and cost-effective care," Pace said.

About Health Diagnostic Laboratory, Inc.

Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes, and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Clinical Health Consultants at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, Inc., visit www.hdlabinc.com.


'/>"/>
SOURCE HDL, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Best Healthcare Websites of 2013 to be Named by Web Marketing Association in 17th Annual WebAward Competition
2. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
3. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
4. Steven Ek Named President and CEO of Arthrosurface
5. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
6. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
7. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
8. Prime Therapeutics named a 2013 National Top Workplace
9. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
10. Cohera Medical Named Winner of 2013 Carnegie Science Award
11. PharmaNet/i3 Renamed inVentiv Health Clinical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:4/29/2016)... 2016  In the next ten years, the ... systems dependent on CRTs monitors to those reliant on ... Medical monitors and will automatically sync to existing ... foreseeable benefits to this technological advancement, it also ... to be replaced in order to be LCD ...
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... “Engineering Bubbles,” an oil painting submitted ... ARRS Art Forum held recently at the Annual Meeting in Los Angeles. The first ... ARRS members and Annual Meeting attendees. , “Through art I hope to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Over $60 Billion is spent ... pet gear and toys, leading product review site for Toys, Tots, Pets & More ... at their Spring Showcase at the Metropolitan Pavilion in New York City. , ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... has announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty ... the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled ...
(Date:5/2/2016)... ... ... According to an American Psychological Association article, the Centers for Disease ... of 18. Of those who survive, many still face effects as they reach adulthood. ... new book, Lyah! Lyah! Pants on Fyah!, she shares stories from women who are ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... Research & Analytics EVP and GM Jim Callandrillo and Duane Reed, VP ... 55th Annual Pharmaceutical Business Intelligence and Research Group (PBIRG) General Meeting ...
Breaking Medicine News(10 mins):